Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement

Fiche du document

Auteurs
Date

2005

Types de document
Périmètre
Langue
Identifiants
Source

Serveur académique Lausannois

Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1093/brain/awh415

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/15689357

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1460-2156

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_A90C1B92E9061

Collection

Serveur Académique Lausannois

Organisation

Université de Lausanne et CHUV

Licences

info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer

Mots-clés 0

Anticonvulsants/therapeutic use; Encephalitis/diagnosis; Encephalitis/etiology; Encephalitis/immunology; Encephalitis/therapy; Epilepsy/etiology; Immunotherapy/methods; T-Lymphocytes, Cytotoxic/immunology

Sujets proches En

Rasmussen's encephalitis Rasmussen syndrome Kozhevnikov's encephalitis Rasmussen encephalitis Kozhevnikov encephalitis Rasmussen's syndrome

Citer ce document

C.G. Bien et al., « Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement », Serveur académique Lausannois, ID : 10.1093/brain/awh415

Métriques

Partage / Export

Résumé 0

Rasmussen encephalitis (RE) is a rare but severe immune-mediated brain disorder leading to unilateral hemispheric atrophy, associated progressive neurological dysfunction and intractable seizures. Recent data on the pathogenesis of the disease, its clinical and paraclinical presentation, and therapeutic approaches are summarized. Based on these data, we propose formal diagnostic criteria and a therapeutic pathway for the management of RE patients.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en